Levosimendan for patients with impaired left ventricular function undergoing cardiac surgery

Department of Cardiothoracic Surgery, Prince of Wales Hospital, Barker Street, Randwick, New South Wales, 2031, Australia *Corresponding author. Tel.: +61-2-9382-0490; fax: +61-2-93820493. E-mail address : tokuda{at}mxb.mesh.ne.jp (Y. Tokuda). The efficacy of levosimendan treatment for a low cardiac...

Full description

Saved in:
Bibliographic Details
Published inInteractive cardiovascular and thoracic surgery Vol. 5; no. 3; pp. 322 - 326
Main Authors Tokuda, Yoshiyuki, Grant, Peter W, Wolfenden, Hugh D, Manganas, Con, Lyon, William J, Murala, John S.K
Format Journal Article
LanguageEnglish
Published England Eur Assoc Cardio Surg 01.06.2006
Online AccessGet full text

Cover

Loading…
More Information
Summary:Department of Cardiothoracic Surgery, Prince of Wales Hospital, Barker Street, Randwick, New South Wales, 2031, Australia *Corresponding author. Tel.: +61-2-9382-0490; fax: +61-2-93820493. E-mail address : tokuda{at}mxb.mesh.ne.jp (Y. Tokuda). The efficacy of levosimendan treatment for a low cardiac output status following cardiac surgery has not been established. Here, we review our initial experiences of the perioperative use of levosimendan. This study is a retrospective uncontrolled trial. Nine patients who underwent cardiac surgery, and developed a low cardiac output status resistant to conventional inotropic support, were given levosimendan. The mean preoperative ejection fraction was 35.2±3.4%. All patients were on concomitant inotropic agents and had previously undergone intra-aortic balloon pumping. Cardiac index increased immediately from 2.14±0.33 l/min/m 2 at baseline to 2.41±0.31 ( P =0.02) at 1 h, rising to 2.67±0.43 ( P <0.001) at 4 h after the loading dose was started. Similarly, the systemic vascular resistance index decreased from 2350±525 dynes/s/cm –5 /m 2 at baseline to 1774±360 ( P =0.002) at 4 h. In the case of all but one of the patients, either the dose of the concomitant inotropic support or the balloon pumping could be weaned down within 24 h after completion of the levosimendan infusion. No withdrawal of levosimendan was required. Levosimendan could constitute a new therapeutic option for postoperative low cardiac output. Key Words: Levosimendan; Postoperative care; Impaired ventricular function Related Articles ICVTS on-line discussion A Mohamed Fahmy Ibrahim Interactive CardioVascular and Thoracic Surgery 2006 5: 326. [Full Text] [PDF] ICVTS on-line discussion B Alexander Wahba Interactive CardioVascular and Thoracic Surgery 2006 5: 326. [Full Text] [PDF]
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1569-9293
1569-9285
DOI:10.1510/icvts.2005.122390